Showing results (161-170 of 169) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Molecular and Cellular Pediatrics|April 6, 2025
Hand hygiene versus additional non-sterile gloves and gowns use to prevent sepsis in preterm infants colonized with multi-resistant drug bacteria: the study protocol of the cluster-randomized, cross-over, non-inferiority BALTIC trialKirstin Faust, Clara Haug, Julia Pagel, et al.
Expert Review of Clinical Pharmacology|April 1, 2021
Prescription patterns of antiseizure drugs in tuberous sclerosis complex (TSC)-associated epilepsy: a multicenter cohort study from Germany and review of the literatureAdam Strzelczyk, Janina Grau, Thomas Bast, et al.
The Lancet. Rheumatology|April 4, 2022
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort studyJochen Pfeifer, Bernhard Thurner, Christoph Kessel, et al.
Orphanet Journal of Rare Diseases|June 22, 2021
Direct and indirect costs and cost-driving factors of Tuberous sclerosis complex in children, adolescents, and caregivers: a multicenter cohort studyJanina Grau, Johann Philipp Zöllner, Susanne Schubert-Bast, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|October 21, 2021
Health-related quality of life in children and adolescents with tuberous sclerosis complex and their caregivers: A multicentre cohort study from GermanyLaurent M Willems, Susanne Schubert-Bast, Janina Grau, et al.
CNS Drugs|July 18, 2021
Efficacy, Retention and Tolerability of Everolimus in Patients with Tuberous Sclerosis Complex: A Survey-Based Study on Patients' PerspectivesLaurent M Willems, Felix Rosenow, Susanne Schubert-Bast, et al.
The Lancet. Respiratory Medicine|April 21, 2024
Early postnatal high-dose fat-soluble enteral vitamin A supplementation for moderate or severe bronchopulmonary dysplasia or death in extremely low birthweight infants (NeoVitaA): a multicentre, randomised, parallel-group, double-blind, placebo-controlled, investigator-initiated phase 3 trialSascha Meyer, Johannes Bay, Axel R Franz, et al.
Eclinicalmedicine|December 8, 2025
Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trialMartin Poryo, Ludwig Gortner, Johannes Bay, et al.
Eclinicalmedicine|November 10, 2025
Corrigendum to "Two-year outcomes after early postnatal high-dose fat-soluble enteral vitamin A supplementation in extremely low birth weight infants: follow-up of the NeoVitaA randomized controlled trial"Martin Poryo, Ludwig Gortner, Johannes Bay, et al.
Pageof 17